Stockhub

Bone Biologics Corporation: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

12 August 2022

26 July 2022

  • curprev 21:4821:48, 26 July 2022‎ Chris talk contribs‎ 914 bytes +914‎ Created page with "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platf..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Bone_Biologics_Corporation’